ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal
Business Model:
Revenue: $0
Employees: 1,001-5,000
Zystor was acquired by
BioMarin Pharmaceutical.
The acquisition happend on 2010-08-17.
Details of the transaction were not public
Address:
City: Milwaukee
State: Wisconsin
Zip:
Country: United States
ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal storage diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2004 | Series A | $0 |
Apjohn ventures Hexagon Investments Mason Wells Prolog Ventures State of Wisconsin Investment Board Stonehenge Capital Venture Investors Apjohn ventures Hexagon Investments Mason Wells Prolog Ventures State of Wisconsin Investment Board Stonehenge Capital Venture Investors |
12/2004 | Series A | 7 | $8.5M |
Apjohn ventures Hexagon Investments Mason Wells Prolog Ventures State of Wisconsin Investment Board Stonehenge Capital Venture Investors Apjohn ventures Hexagon Investments Mason Wells Prolog Ventures State of Wisconsin Investment Board Stonehenge Capital Venture Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|